Abstract:Despite considerable research efforts, it is still not clear which mechanisms underlie neuronal cell death in neurodegenerative diseases. During the last 20 years, multiple pathways have been identified that can execute regulated cell death (RCD). Among these RCD pathways, apoptosis, necroptosis, pyroptosis, ferroptosis, autophagy-related cell death, and lysosome-dependent cell death have been intensively investigated. Although RCD consists of numerous individual pathways, multiple common proteins have been identified that allow shifting from one cell death pathway to another. Another layer of complexity is added by mechanisms such as the endosomal machinery, able to regulate the activation of some RCD pathways, preventing cell death. In addition, restricted axonal degeneration and synaptic pruning can occur as a result of RCD activation without loss of the cell body. RCD plays a complex role in neurodegenerative processes, varying across different disorders. It has been shown that RCD is differentially involved in Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS), among the most common neurodegenerative diseases. In AD, neuronal loss is associated with the activation of not only necroptosis, but also pyroptosis. In ALS, on the other hand, motor neuron death is not linked to canonical necroptosis, whereas pyroptosis pathway activation is seen in white matter microglia. Despite these differences in the activation of RCD pathways in AD and ALS, the accumulation of protein aggregates immunoreactive for p62/SQSTM1 (sequestosome 1) is a common event in both diseases and many other neurodegenerative disorders. In this review, we describe the major RCD pathways with clear activation in AD and ALS, the main interactions between these pathways, as well as their differential and similar involvement in these disorders. Finally, we will discuss targeting RCD as an innovative therapeutic concept for neurodegenerative diseases, such as AD and ALS. Considering that the execution of RCD or "cellular suicide" represents the final stage in neurodegeneration, it seems crucial to prevent neuronal death in patients by targeting RCD. This would offer valuable time to address upstream events in the pathological cascade by keeping the neurons alive.

Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

New Insights on the Regulation of Programmed Cell Death by Bcl-2 Family Proteins at the Mitochondria: Physiological and Pathophysiological Implications

Cell cycle regulation of neuronal apoptosis in development and disease

Axon & dendrite degeneration: its mechanisms and protective experimental paradigms.

Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

Protease Regulation: the Yin and Yang of Neural Development and Disease

Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review

Mitochondrial mechanisms of neural cell apoptosis

The Bcl2 family: regulators of the cellular life-or-death switch

Recent advances in canonical versus non-canonical Ca2+-signaling-related anti-apoptotic Bcl-2 functions and prospects for cancer treatment

Autophagy in Axonal and Dendritic Degeneration

The Role of TNF Related Apoptosis-Inducing Ligand in Neurodegenerative Diseases.

The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death

The therapeutic potential of targeting regulated non-apoptotic cell death

The BCL-2 protein family: opposing activities that mediate cell death

Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis

Axon Degeneration Gated by Retrograde Activation of Somatic Pro-apoptotic Signaling

Therapeutics targeting BCL2 family proteins

Control of Cell Death in Health and Disease

Bcl-2 proteins and calcium signaling: complexity beneath the surface